Renal Cancer - Results from #9020

Allogeneic hematopoietic cell transplantation for renal cell carcinoma: Ten years after - Abstract April 19, 2011

Case report of kidney cancer from JOUM 2010 - Abstract April 14, 2011

Fluid intake and incidence of renal cell carcinoma in UK women - Abstract April 14, 2011

Update on the different histological types of renal cell carcinoma and their specific treatment - Abstract April 13, 2011

Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy - Abstract April 13, 2011

CURy 2011 - Open partial nephrectomy for small renal mass - Slide Presentation April 13, 2011

CURy 2011 - Localized kidney cancer - Case discussion panel: 3cm tumor in a 70-year old patient - Slide Presentation April 13, 2011

CURy 2011 - Are there still contraindications to partial nephrectomy? - Slide Presentation April 13, 2011

Importance of brain‑type fatty acid binding protein for cell-biological processes in human renal carcinoma cells - Abstract April 12, 2011

Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma? - Abstract April 11, 2011

Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens - Abstract April 11, 2011

Economic burden of renal cell carcinoma in the US: Part II - an updated analysis - Abstract April 8, 2011

Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma - Abstract April 8, 2011

Exposure-response relationships in patients with metastatic renal cell carcinoma receiving sunitinib: Maintaining optimum efficacy in clinical practice - Abstract April 7, 2011

Economic burden of renal cell carcinoma: Part I - an updated review - Abstract April 7, 2011

How long can patients with renal cell carcinoma wait for surgery without compromising pathological outcomes? - Abstract April 6, 2011

The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach? - Abstract April 6, 2011

EAU 2011 - Head-to-head comparison of the most relevant integrated prognostic systems predicting cancer-specific survival in clear cell renal cell carcinoma - Session Highlights April 6, 2011

EAU 2011 - External validation of Karakiewicz preoperative and postoperative prognostic nomograms for renal cell carcinoma. A multicentre European study - Session Highlights April 6, 2011

A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma - Abstract April 5, 2011

Page 452 of 455